FluoGuide A/S Ordinary Shares FLUO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FLUO is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- SEK 50.00
- Day Range
- SEK 48.60–52.40
- 52-Week Range
- SEK 41.15–99.80
- Bid/Ask
- SEK 49.85 / SEK 50.80
- Market Cap
- SEK 620.19 Mil
- Volume/Avg
- 4,606 / 8,794
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
FluoGuide A/S is a Denmark based company engaged in developing surgical solutions. Its technology includes uPAR which is a part of a proteolytic system and FG001 is a product injected into the patient's vein prior to surgery.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.fluoguide.com
Comparables
Valuation
|
Metric
|
FLUO
|
DEMANT
|
7979
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 29.61 | 13.21 |
Price/Book Value | 32.86 | 7.98 | 1.45 |
Price/Sales | — | 3.33 | 1.69 |
Price/Cash Flow | — | 17.27 | 14.06 |
Price/Earnings
FLUO
DEMANT
7979
Financial Strength
|
Metric
|
FLUO
|
DEMANT
|
7979
|
|---|---|---|---|
Quick Ratio | 1.73 | 0.84 | 2.69 |
Current Ratio | 1.74 | 1.37 | 5.05 |
Interest Coverage | −1,022.00 | 6.91 | 180.72 |
Quick Ratio
FLUO
DEMANT
7979
Profitability
|
Metric
|
FLUO
|
DEMANT
|
7979
|
|---|---|---|---|
Return on Assets (Normalized) | −131.91% | 8.40% | 9.57% |
Return on Equity (Normalized) | −177.78% | 28.27% | 11.56% |
Return on Invested Capital (Normalized) | −159.67% | 12.19% | 10.88% |
Return on Assets
FLUO
DEMANT
7979
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Mpqhppmz | Vvdt | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Jqwrvdgg | Tbhfcpr | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Wkbvlcbf | Hxtws | $108.2 Bil | |
MRNA
| Moderna Inc | Tdvbnsh | Vvr | $50.9 Bil | |
ARGX
| argenx SE ADR | Stmrslmx | Mcmyg | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Gpstngcf | Wspn | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vwvcjml | Cflfv | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Kzrwszmh | Hkyqldg | $14.6 Bil | |
INCY
| Incyte Corp | Dyhwzrws | Snkjrs | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Mmqlddlhlt | Czzsfwx | $12.3 Bil |